Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 15 of 15
Allergy Therapeutics has major opportunity in US, says Stifel
Just for the grass vaccine allergy alone Stifel is predicting sales of US$400mln by 2023.
Investments and investor services
Proactive news highlights including Metminco, Versarien, Proxama, Landore, REM, DP Poland and more
A look at the big news from the world of small caps...
London stocks rise on Greek news and drug firm boost
Syriza emerged as the largest party in the latest Greek poll
Archive
Proactive news summary: African Potash, Falcon Oil, Allergy Therapeutics, Northcote, Rightster ...
It's deja vu all over again for African Potash as it inked another fertiliser deal.
Allergy Therapeutics recruits first patient to dosing trial
The company continues to make significant headway on a number of different fronts.
Investments and investor services
Proactive news highlights including Tethys, Rightster, Fastjet, Tern, Amur, Petropavlovsk and more
On a busy day in the world of small caps, Tethys Petroleum caught the eye...
Archive
Proactive news summary, including Atlantic Coal, Breedon Aggregates, ANGLE, cloudbuy, Madagascar Oil and Tethys Petroleum
Atlantic Coal shares advanced on Thursday as it saw anthracite sales rise strongly...
Investments and investor services
Risers & Fallers including Madagascar Oil, Allergy Therapeutics, Howden Joinery, Flybe and more
Atlantic Coal rose on improved sales while Daily Mail dropped after a decline in first quarter revenue.
Allergy Therapeutics' sales beat forecasts
Revenues on a constant currency basis are expected to be £46.6mln
Investments and investor services
Proactive news summary: Accesso, ATTRAQT, DiamondCorp, Europa, LGO, Providence, Strategic Mins ...
A number of technology companies were celebrating contract wins today.
ROUNDUP - Allergy Therapeutics shares rise as it reveals positive results from dust mite study
Allergy Therapeutics looks like it has another promising product for the corporate medicine chest.
Allergy Therapeutics to present dust mite data at key conference
Acarovac has been Allergy’s strongest growing treatment in Spain this year.
Archive
Greece saga pushes FTSE100 firmly lower
The full weight of the Greek saga made its presence felt on Footsie at the close....
Archive
Proactive news summary: Xtract Resources, Wolf Minerals, ValiRx, Trap Oil, Sula Iron & Gold ...
Lekoil was boosted by the chief executive topping up his holding but there was some grim news elsewhere from the oil sector.
Allergy Therapeutics’ momentum renewed with US programme kick-start
Allergy Therapeutics has renewed momentum - as its announcement this morning showing a kick-start to its US growth ambitions aptly demonstrated.
Allergy Therapeutics resumes development of allergy treatment in US
Allergy Therapeutics revealed it is returning to clinical development of Pollinex Quattro Grass - kick-starting the process of getting the firm's first product approved for the US market.
Investments and investor services
Proactive news summary - Ariana Resources, Alba Minerals, Falcon Oil & Gas, Premier African Minerals
Miners and oil stocks took to the stage today on a busy day for small caps.